One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?.
Messerli, Franz H. MD;Â Bavishi, Chirag MD, MPH;Â Bangalore, Sripal MD, MHA
Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
MacIntyre, Iain M. PhD;Â Turtle, Emma J. MD;Â Farrah, Tariq E. MBChB;Â Graham, Catriona MSc;Â Dear, James W. PhD;Â Webb, David J. DSc;Â for the PATH-BP (Paracetamol in Hypertension-Blood Pressure) Investigators
Acetaminophen-Induced Hypertension: Where Have All the "Safe" Analgesics Gone?.
Smith, Steven M. PharmD, MPH;Â Cooper-DeHoff, Rhonda M. PharmD, MS
Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality).
Yafasova, Adelina MD;Â Butt, Jawad H. MD;Â Elming, Marie B. MD, PhD;Â Nielsen, Jens C. MD, DMSc;Â Haarbo, Jens MD, DMSc;Â Videbaek, Lars MD, PhD;Â Olesen, Line L. MD;Â Steffensen, Flemming H. MD, PhD;Â Bruun, Niels E. MD, DMSc;Â Eiskjaer, Hans MD, DMSc;Â Brandes, Axel MD;Â Thogersen, Anna M. MD, DMSc;Â Egstrup, Kenneth MD, DMSc;Â Gustafsson, Finn MD, DMSc;Â Hassager, Christian MD, DMSc;Â Svendsen, Jesper H. MD, DMSc;Â Hofsten, Dan E. MD, PhD;Â Torp-Pedersen, Christian MD, DMSc;Â Pehrson, Steen MD, DMSc;Â Thune, Jens J. MD, PhD;Â Kober, Lars MD, DMSc
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyzes From the FIGARO-DKD Trial.
Filippatos, Gerasimos MD;Â Anker, Stefan D. MD, PhD;Â Agarwal, Rajiv MD, MS;Â Ruilope, Luis M. MD;Â Rossing, Peter MD;Â Bakris, George L. MD;Â Tasto, Christoph PhD;Â Joseph, Amer MBBS;Â Kolkhof, Peter PhD;Â Lage, Andrea MD;Â Pitt, Bertram MD;Â on behalf of the FIGARO-DKD Investigators
Myocardial Rev-erb-Mediated Diurnal Metabolic Rhythm and Obesity Paradox.
Song, Shiyang MD *,,;Â Tien, Chih-Liang PhD*,;Â Cui, Hao PhD*,;Â Basil, Paul PhD;Â Zhu, Ningxia PhD;Â Gong, Yingyun PhD;Â Li, Wenbo PhD;Â Li, Hui MS;Â Fan, Qiying PhD;Â Min Choi, Jong PhD;Â Luo, Weijia PhD;Â Xue, Yanfeng PhD;Â Cao, Rui PhD;Â Zhou, Wenjun PhD;Â Ortiz, Andrea R. BS;Â Stork, Brittany BS;Â Mundra, Vatsala BS;Â Putluri, Nagireddy PhD;Â York, Brian PhD;Â Chu, Maoping MD, PhD;Â Chang, Jiang MD, PhD;Â Yun Jung, Sung PhD;Â Xie, Liang PhD;Â Song, Jiangping MD, PhD;Â Zhang, Lilei MD, PhD;Â Sun, Zheng Ph.D.
Rev-erb-Mediated Regulation of Cardiac Metabolism in the Obesity Paradox.
Rabinovich-Nikitin, Inna PhD;Â Kirshenbaum, Lorrie A. PhD
ZEB2 Shapes the Epigenetic Landscape of Atherosclerosis.
Cheng, Paul MD, PhD*,;Â Wirka, Robert C. MD*,;Â Shoa Clarke, Lee MD;Â Zhao, Quanyi PhD;Â Kundu, Ramendra PhD;Â Nguyen, Trieu MS;Â Nair, Surag PhD;Â Sharma, Disha PhD;Â Kim, Hyun-jung PhD;Â Shi, Huitong PhD;Â Assimes, Themistocles MD, PhD;Â Brian Kim, Juyong MD;Â Kundaje, Anshul PhD;Â Quertermous, Thomas MS, MD
One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.
Gonzalez-Juanatey, Jose R. MD;Â Lemesle, Gilles MD, PhD;Â Puymirat, Etienne MD, PhD;Â Ducrocq, Gregory MD, PhD;Â Cachanado, Marine MSc;Â Arnaiz, Joan Albert MD, PhD;Â Martinez-Selles, Manuel MD, PhD;Â Silvain, Johanne MD, PhD;Â Ariza-Sole, Albert MD;Â Ferrari, Emile MD;Â Calvo, Gonzalo MD, PhD;Â Danchin, Nicholas MD;Â Avendano-Sola, Cristina MDE;Â Rousseau, Alexandra PhD;Â Vicaut, Eric MD, PhD;Â Gonzalez-Ferrero, Teba MD;Â Steg, Philippe Gabriel MD, PhD;Â Simon, Tabassome MD, PhD;Â for the REALITY Investigators
